Annual Cash & Cash Equivalents
$2.58B$449.56M-14.86%
Summary
- Current Value
- As of today, TAK annual cash & cash equivalents is $2.58B, down -14.86% on
- Historical Performance
- TAK annual cash & cash equivalents is down -63.21% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- TAK annual cash & cash equivalents is currently -84.79% below its historical high of $16.93B set on
- 3-Year Low Comparison
- TAK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- TAK annual cash & cash equivalents is higher than 96.44% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $2.58B | -14.9% | -63.2% | – | -72.8% | |
| Quarterly Cash & Cash Equivalents | $4.61B | -23.2% | -16.3% | -22.8% | – | |
| Price | $15.90 | +19.1% | +2.0% | -11.2% | -33.1% | |
| Annual Current Assets | $16.86B | -0.3% | -21.1% | -26.3% | +0.2% | |
| Annual Total Liabilities | $48.90B | -5.5% | -20.8% | – | +600.9% | |
| Annual Working Capital | $98.11M | -94.0% | -97.3% | -96.4% | -99.2% | |
| Annual Net Income | $709.37M | -28.9% | -65.4% | +74.1% | -78.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $7.00B | N/A | -63.2% |
| 5Y | $8.74B | -70.5% | |
| All | $16.93B | -84.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.58B | at low | |
| 5Y | $2.58B | at low | |
| All | $1.73B | +48.6% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $2.58B | -14.9% | |
| $3.02B | -24.5% | |
| $4.01B | -42.7% | |
| $7.00B | -19.9% | |
| $8.74B | +37.9% |
| Year | Value | Change |
|---|---|---|
| $6.34B | +79.8% | |
| $3.53B | +4.5% | |
| $3.38B | -32.3% | |
| $4.98B | -16.2% | |
| $5.95B | - |
FAQ
What is the current annual cash & cash equivalents of TAK?
As of today, TAK annual cash & cash equivalents is $2.58B
What is 1-year change in TAK annual cash & cash equivalents?
TAK annual cash & cash equivalents is down -14.86% year-over-year
What is 3-year change in TAK annual cash & cash equivalents?
TAK annual cash & cash equivalents is down -63.21% over the past 3 years
How far is TAK annual cash & cash equivalents from its all-time high?
TAK annual cash & cash equivalents is currently -84.79% below its historical high of $16.93B set on March 31, 2008
How does TAK annual cash & cash equivalents rank versus sector peers?
TAK annual cash & cash equivalents is higher than 96.44% of companies in Healthcare sector
When is TAK next annual earnings release?
As of today, the next annual earnings release for TAK has not been scheduled
Quarterly Cash & Cash Equivalents
$4.61B$2.19B+90.43%
Summary
- Current Value
- As of today, TAK quarterly cash & cash equivalents is $4.61B, up +90.43% on
- Historical Performance
- TAK quarterly cash & cash equivalents is down -23.16% year-over-year, and down -16.32% over the past 3 years
- All-Time High Comparison
- TAK quarterly cash & cash equivalents is currently -56.25% below its historical high of $10.55B set on
- 3-Year Low Comparison
- TAK quarterly cash & cash equivalents is +125.60% above its 3-year low of $2.05B reached on
- Sector Comparison
- TAK quarterly cash & cash equivalents is higher than 97.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.61B | +90.4% | -23.2% | -16.3% | -22.8% | |
| Annual Cash & Cash Equivalents | $2.58B | – | -14.9% | -63.2% | – | |
| Price | $15.90 | +10.0% | +19.1% | +2.0% | -11.2% | |
| Quarterly Current Assets | $19.78B | +13.7% | -7.4% | +4.3% | -19.3% | |
| Quarterly Total Liabilities | $49.69B | +0.6% | -7.1% | -8.7% | -32.3% | |
| Quarterly Working Capital | $5.29B | +122.3% | +13.4% | +116.3% | -36.3% | |
| Quarterly Net Income | -$79.53M | -109.3% | -112.9% | -117.8% | -307.4% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.61B | at high | |
| 3Y | $6.01B | -23.2% | |
| 5Y | $8.74B | -47.2% | |
| All | $10.55B | -56.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.42B | +90.4% | |
| 3Y | $2.05B | +125.6% | |
| 5Y | $2.05B | +125.6% | |
| All | $2.05B | +125.6% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of TAK?
As of today, TAK quarterly cash & cash equivalents is $4.61B
What is TAK quarterly cash & cash equivalents most recent change?
TAK quarterly cash & cash equivalents was up +90.43% on September 1, 2025
What is 1-year change in TAK quarterly cash & cash equivalents?
TAK quarterly cash & cash equivalents is down -23.16% year-over-year
How far is TAK quarterly cash & cash equivalents from its all-time high?
TAK quarterly cash & cash equivalents is currently -56.25% below its historical high of $10.55B set on March 31, 2011
How does TAK quarterly cash & cash equivalents rank versus sector peers?
TAK quarterly cash & cash equivalents is higher than 97.95% of companies in Healthcare sector
When is TAK next earnings release?
The next earnings release for TAK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- TAK Official Website www.takeda.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1395064/000139506425000095/0001395064-25-000095-index.htm
- TAK Profile on Yahoo Finance finance.yahoo.com/quote/TAK
- TAK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tak